These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25053801)

  • 21. The feasibility of two anthropometric indices to identify metabolic syndrome, insulin resistance and inflammatory factors in obese and overweight adults.
    Li G; Wu HK; Wu XW; Cao Z; Tu YC; Ma Y; Li BN; Peng QY; Cheng J; Wu B; Zhou Z
    Nutrition; 2019 Jan; 57():194-201. PubMed ID: 30176572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery.
    Illán-Gómez F; Gonzálvez-Ortega M; Orea-Soler I; Alcaraz-Tafalla MS; Aragón-Alonso A; Pascual-Díaz M; Pérez-Paredes M; Lozano-Almela ML
    Obes Surg; 2012 Jun; 22(6):950-5. PubMed ID: 22527592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study.
    Herder C; Færch K; Carstensen-Kirberg M; Lowe GD; Haapakoski R; Witte DR; Brunner EJ; Roden M; Tabák AG; Kivimäki M; Vistisen D
    Eur J Endocrinol; 2016 Nov; 175(5):367-77. PubMed ID: 27491375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?
    Bahceci M; Gokalp D; Bahceci S; Tuzcu A; Atmaca S; Arikan S
    J Endocrinol Invest; 2007 Mar; 30(3):210-4. PubMed ID: 17505154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial.
    Shi L; Zhu J; Yang P; Tang X; Yu W; Pan C; Shen M; Zhu D; Cheng J; Ye X
    Obes Res Clin Pract; 2017; 11(5):607-615. PubMed ID: 28161303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis.
    Sun WL; Chen LL; Zhang SZ; Wu YM; Ren YZ; Qin GM
    Intern Med; 2011; 50(15):1569-74. PubMed ID: 21804283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TNF-alpha, C-reactive protein and serum adiponectin modified in infertile patients with insulin resistance].
    Vital Reyes VS; López Alarcón M; Zavala Ortega I; Hinojosa Cruz JC; Téllez Velasco S; Gris Calvo J
    Ginecol Obstet Mex; 2008 Nov; 76(11):659-66. PubMed ID: 19065817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principal component 1 score calculated from metabolic syndrome diagnostic parameters is a possible marker for the development of metabolic syndrome in middle-aged Japanese men without treatment for metabolic diseases.
    Mochizuki K; Miyauchi R; Misaki Y; Ichikawa Y; Goda T
    Eur J Nutr; 2013 Feb; 52(1):67-74. PubMed ID: 22160241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.
    Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Stehle P; Egert S
    Eur J Nutr; 2017 Oct; 56(7):2265-2275. PubMed ID: 27423432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.
    El Amrousy D; El-Afify D
    Cytokine; 2020 Nov; 135():155215. PubMed ID: 32731119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.
    Fadaei R; Bagheri N; Heidarian E; Nouri A; Hesari Z; Moradi N; Ahmadi A; Ahmadi R
    Cytokine; 2020 Jan; 125():154832. PubMed ID: 31479874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance.
    Luo R; Li X; Jiang R; Gao X; Lü Z; Hua W
    J Int Med Res; 2012; 40(2):621-30. PubMed ID: 22613423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.
    Kopp HP; Krzyzanowska K; Möhlig M; Spranger J; Pfeiffer AF; Schernthaner G
    Int J Obes (Lond); 2005 Jul; 29(7):766-71. PubMed ID: 15917853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.
    Srikanthan K; Feyh A; Visweshwar H; Shapiro JI; Sodhi K
    Int J Med Sci; 2016; 13(1):25-38. PubMed ID: 26816492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early predictors of microvascular complications in type 1 diabetic patients.
    Abd El-Maksoud AM; El Hefnawy MH; Yahya SM; Seoudi DM; Abdel-Ghaffar AR; Eskander EF; Ahmed HH; Kamal IH
    Clin Biochem; 2009 Sep; 42(13-14):1401-6. PubMed ID: 19559018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Metabolic and Hormonal Derangements and Professional Exposure to Urban Pollution in a High Intensity Traffic Area.
    Molfino A; Amabile MI; Muscaritoli M; Germano A; Alfano R; Ramaccini C; Spagnoli A; Cavaliere L; Marseglia G; Nardone A; Muto G; Carbone U; Triassi M; Fiorito S
    Front Endocrinol (Lausanne); 2020; 11():509. PubMed ID: 32849295
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin, leptin and high sensitivity C-reactive protein values in obese children - important markers for metabolic syndrome?
    Stroescu RF; Mărginean O; Bizerea T; Gafencu M; Voicu A; Doroș G
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):27-31. PubMed ID: 30530892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.